My concern is that it is a vaccine to prevent the recurrence of breast cancer. I think the end point is a couple of years out. But if someone in the group gets cancer is the trial a failure? Does that knock out the legs from the drug?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.